CompletedPhase 1NCT02644460

Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors

Studying Diffuse intrinsic pontine glioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Emory University
Principal Investigator
Thomas Cash, MD
Emory University
Intervention
Abemaciclib(drug)
Enrollment
53 enrolled
Eligibility
2-25 years · All sexes
Timeline
20162023

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02644460 on ClinicalTrials.gov

Other trials for Diffuse intrinsic pontine glioma

Additional recruiting or active studies for the same condition.

See all trials for Diffuse intrinsic pontine glioma

← Back to all trials